PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33831356-5	2021	In addition, miR-93 was found highly expressed in cisplatin or sorafenib-resistant liver cancer tissues.	Sorafenib	63-72	microRNA 9-3	Homo sapiens	13-19	
33831356-6	2021	Interference of miR-93 sensitizes hepatoma cells to cisplatin or sorafenib treatment.	Sorafenib	65-74	microRNA 9-3	Homo sapiens	16-22	
33831356-7	2021	Clinical cohort analysis showed that Hepatocellular carcinoma (HCC) patients with low miR-93 were benefit more from TACE or sorafenib treatment.	Sorafenib	124-133	microRNA 9-3	Homo sapiens	86-92